ORG Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ORG Partners's BMY Position: Q4 2025 in Review
ORG Partners increased its Bristol-Myers Squibb (BMY) stake by 49% in Q4 2025, buying an estimated $21.7K and bringing the position to 1,363 shares worth $73.5K. The position accounts for 0.01% of the portfolio, ranked #504.
ORG Partners first reported a position in BMY in Q2 2023 and has held it in 11 quarters since. The position peaked at $488K in Q3 2023. 2,455 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- ORG Partners held 1,363 shares of Bristol-Myers Squibb worth $73.5K as of Q4 2025.
- ORG Partners bought 451 Bristol-Myers Squibb shares in Q4 2025, an estimated $21.7K.
- Bristol-Myers Squibb made up 0.01% of ORG Partners's portfolio in Q4 2025, its #504 holding.
- ORG Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 11 quarters since.
- ORG Partners's Bristol-Myers Squibb position peaked at $488K in Q3 2023.
- 2,455 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.